Document is current
Any future updates will be listed below
-
Authors
Klötzer, Konstantin A. https://orcid.org/0009-0005-5022-2706
Abedini, Amin https://orcid.org/0000-0002-8875-0070
Li, Shen
Balzer, Michael S. https://orcid.org/0000-0003-0508-1260
Liang, Xiujie https://orcid.org/0000-0002-3471-1068
Levinsohn, Jonathan
Ha, Eunji https://orcid.org/0000-0001-8618-8347
Dumoulin, Bernhard
Hogan, Jonathan J.
Quinn, Ghazal
Bloom, Roy D.
Schuller, Max
Eller, Kathrin https://orcid.org/0000-0002-6214-5008
Halmos, Balazs
Zhang, Nancy R. https://orcid.org/0000-0002-0880-5749
Susztak, Katalin https://orcid.org/0000-0002-1005-3726
- License Information
-
More Information
Article History
Received: 20 July 2024
Accepted: 25 June 2025
First Online: 7 August 2025
Competing interests
: The Susztak lab is supported by Gilead, Novo Nordisk, Novartis, GSK, BIPI, Regeneron, Genentech, ONO and Calico. K.S. is on the scientific advisory boards of Pfizer and Otsuka. The other authors declare no competing interests.
